Optimizing Pembrolizumab Therapy With Timing and Intensification With Axitinib
Condition(s):Renal Cell CancerLast Updated:August 2, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Renal Cell CancerLast Updated:August 2, 2022Withdrawn
Condition(s):Metastatic Clear Cell Renal CancerLast Updated:November 13, 2013Completed
Condition(s):Kidney CancerLast Updated:January 10, 2014Unknown status
Condition(s):Kidney CancerLast Updated:November 18, 2023Active, not recruiting
Condition(s):Advanced Clear Cell Renal Cell Carcinoma; Metastatic Clear Cell Renal Cell Carcinoma; Stage IV Renal Cell Cancer AJCC v8Last Updated:December 7, 2023Active, not recruiting
Condition(s):Localized Renal Cell CarcinomaLast Updated:July 28, 2009Unknown status
Condition(s):Kidney CancerLast Updated:June 5, 2013Completed
Condition(s):Kidney CancerLast Updated:October 20, 2011Completed
Condition(s):Renal Cell Cancer; Advanced Renal Cell CancerLast Updated:August 17, 2017Unknown status
Condition(s):Kidney CancerLast Updated:November 7, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.